Document ID: chunk:federal_register_of_legislation:F2023C00456:schedule:3:p19
Version: federal_register_of_legislation:F2023C00456
Segment Type: schedule
Provision Reference: sch 3 (pt 19/27)
Character Range: 51237–54123

such as by including the statement 'contains homoeopathic preparations of' adjacent to the list of homoeopathic ingredients, or by prefacing the name of the homoeopathic active ingredient with the term 'homoeopathic'.

       (5) Sunscreen preparations

       If:

           (a) the medicine is a sunscreen preparation; and

           (b) is enclosed in a container with a capacity of not more than 25 millilitres,

       then, in relation to compliance with sections 8 and 9, it shall be sufficient if

              (i) the sun protection factor is displayed in a text size of not less than 1.5 millimetres; and

              (ii) all other information is displayed in a text size of not less than 1.0 millimetres.

       (6) Medicine kits

        The label on a package that, together with medicines, constitutes a medicine kit must include the following information:

           (a) the name given to the kit; and

           (b) the name and contact details of the sponsor of the kit; and

           (c) the name of each of the medicines within the kit and its dosage form; and

           (d) the name, and quantity or proportion, of all active ingredients in each of the medicines within the kit; and

           (e) the quantity of each medicine within the kit; and

           (f) the batch number of the kit preceded by the batch number prefix; and

           (g) an expiry date for the kit, being the earliest expiry date of the medicines within the kit, preceded by the expiry date prefix; and

           (h) any warning statements that relate to any of the medicines within the kit; and

           (i) storage conditions applicable to the kit, being the most restrictive of the storage conditions for any of the medicines within the kit; and

           (j) the listing number given to the kit, set out on the label consistent with the requirements specified in the Regulations.

                   Note: The label on the container and on the primary pack (if any) of each medicine within a medicine kit must comply with the requirements of this Order.

       (7) Small containers

       If:

           (a) the medicine is enclosed in a small container; and

           (b) the container is enclosed in a primary pack, the label of which complies with sections 8 and 9 and subsection 10(1) (if applicable),

       then, in relation to compliance of the label on the container with sections 8 and 9 and subsection 10(1) (if applicable), it shall be sufficient if the following information is displayed in a text size of not less than 2 millimetres:

       (c) the name of the medicine; and

       (d) the name(s) of all active ingredients in the medicine, unless there are four or more active ingredients;

       and the following information is displayed in a text size of not less than 1.5 millimetres:

           (e) where there are four or more active